Subtle Medical Advances GenAI Innovation in Radiology with NVIDIA
Leveraging NVIDIA’s Latest GPU Architecture to Accelerate Innovations in Ultra-Low-Dose Imaging and Enhanced Lesion Visualization MENLO PARK, Calif., March 18, 2025 /PRNewswire/ — Medical imaging today faces several critical challenges. Imaging modalities like MRI, PET, and CT are used in... Read More →
Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry’s first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan
PARIS and SAN FRANCISCO, March 18, 2025 /PRNewswire/ — Moon Surgical, a French-American pioneer in surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for ScoPilot. Enabled by NVIDIA Holoscan, a real-time sensing platform designed to... Read More →
Why these 10 medical device makers are the most innovative in the world featuring Bruin Biometrics
Whether improving cardio care or reducing surgery recovery time, these medical device companies stand out. Bruin Biometrics For helping detect bedsores in patients regardless of skin color Bedsores, also known as pressure ulcers, fly under the radar but impact 2.5... Read More →
Subtle Medical’s SubtleHD™ Receives CE Mark, Expanding Access to AI-Powered MRI Enhancement Across Europe
SubtleHD sets a new benchmark in image quality and speed for European MRI providers. MENLO PARK, Calif., March 17, 2025 /PRNewswire/ — Subtle Medical, a global leader in AI-powered medical imaging enhancement, announced today that SubtleHD™ has received CE Mark... Read More →
Wellinks and CareAbout Health Partner to Expand Value-Based COPD Management in New Jersey and Florida
Collaboration Enhances Access to Value-Based Care for COPD Patients NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) — Wellinks, a digital healthcare company specializing in Chronic Obstructive Pulmonary Disease (COPD) management, today announced a strategic partnership with CareAbout Health, a... Read More →
Cancer: Biotech NovaGray rolls out its radiotherapy tolerance test
Montpellier-based startup NovaGray aims to revolutionize cancer treatment using radiotherapy with a predictive radiation sensitivity test. A strategic partnership paves the way for large-scale industrialization. Radiotherapy relies on the use of a variety of rays that target and damage tumors,... Read More →
RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product
The Company Received Approval in Multiple European Countries to Initiate this Key Study Necessary for Commercial Product Approval LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has received regulatory and ethics committee approvals in multiple European countries to conduct its pivotal... Read More →
Maria Artunduaga, Founder and CEO of Samay selected for Inc. Magazine’s 2025 Female Founders list
For developing a non-invasive lung function monitoring device to support people with respiratory conditions, conducting extensive clinical trials, and securing the largest funding round for a Latina-led medtech company in the U.S. Read More
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast-growing company in spine surgery innovation, and eCential Robotics, an expert company... Read More →
Implantable Bioelectronic Device to Reverse Degenerative Disc Disease featuring Discure Technologies
The Discure System from Discure Technologies Ltd. is a bioelectronic treatment for mid-stage degenerative disc disease (DDD), providing a minimally invasive, outpatient procedure that reduces pain and restores spine function. The Discure System from Discure Technologies Ltd. is changing the... Read More →